News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape
    Monday, July 15, 2024
    News & Perspective Drugs & Diseases CME & Education Video Decision Point
    Perspective > Medscape Medical News

    Medscape Medical Minute

    F. Perry Wilson, MD, MSCE

    July 15, 2024

    Today on the Medscape Medical Minute: The European Medicines Agency warns of aspiration risk in patients taking GLP-1s who undergo anesthesia; a Medscape commentary defends new guidelines on vitamin D supplementation and testing; and children who inhale secondhand e-cigarette vapor are exposed to significantly less nicotine than with secondhand cigarette smoke.

    In Today's Episode

    F. Perry Wilson, MD, MSCE, is an associate professor of medicine and director of the Clinical and Translational Research Accelerator at the Yale School of Medicine.

    Comments

    Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

    processing....

    Feedback
    Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
    Find Us On
    About
    About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
    Membership
    Become a Member About You Professional Information Newsletters & Alerts Market Research
    App
    Medscape
    Editions
    English Deutsch Español Français Português UK
    All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.